About
Basic Data Updated:
3 days agoThe manufacturing of pharmaceutical products is the main focus of Biophore India Pharmaceuticals Private Limited. This company, according to its credit rating report, is known for its exceptional R&D services in drug discovery and process development. Additionally, the company is also responsible for supplying API's to various domestic pharma companies through its associate companies. BIPPL's diverse product portfolio includes biophore focuses, tianeptine medicine, and epinastine medicine. These products cover a wide range of 30 therapeutic segments, including oncology medications, contrast and diagnostic media. With a strong commitment to innovation, BIPPL has filed around 70 DMFs and 50 patents. The company was established in 2007 and has its registered office situated in Hyderabad, Tel... Read More
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24232TG2007PTC053381 |
| Company No. | 053381 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 29 Mar 2007 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Products or Services related to Biophore India Pharmaceuticals Private Limited
Environment Protection Services
Project Feasibility Studies
Construction Service
Dietary Supplements
Financials of Biophore India Pharmaceuticals Private Limited
Biophore India Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.69% decrease. The company also saw a substantial improvement in profitability, with a 43.88% increase in profit. The company's net worth Soared by an impressive increase of 35.97%.
Enhance accessibility to Biophore India Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Biophore India Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Biophore India Pharmaceuticals Private Limited
Unlock and access historical data on people associated with Biophore India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
Jagadeesh Rangisetty
Managing DirectorAppointment Date: 29-Mar-2007
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Jul 2022 | ₹27.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Mar 2021 | ₹1.28 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Feb 2021 | ₹1.28 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biophore India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biophore India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Glopec International (India) Private Limited
Active
13 years 5 months Harcharan Singh is a mutual person
Azico Biophore India Private Limited
Active 15 years 5 months Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Leiutis Pharmaceuticals Llp
Active 2 years 11 months Madhusudana Kothapalli, Jagadeesh Rangisetty and 2 more are mutual person
Zenara Pharma Private Limited
Active 20 years 1 month Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Alithia Pharmaceuticals Private Limited
Active 2 years 10 months Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
Sionc Pharmaceuticals Private Limited
Active 16 years 3 months Jagadeesh Rangisetty and Manikreddy Pullagurla are mutual person
_PRIVATE_LIMITED.webp)
Recent activity within the organization
Charges
A charge with Others of Rs. 27.00 cr registered on 12 Jul 2022 with Charge ID 100600081 was modified on 03 Oct 2023.
03 Oct 2023Charges
A charge with Others of Rs. 55.64 cr registered on 25 Mar 2015 with Charge ID 10585647 was modified on 03 Oct 2023.
03 Oct 2023Annual General Meeting
Biophore India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Biophore India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge with Others amounted to Rs. 27.00 cr with Charge ID 100600081 was registered on 12 Jul 2022.
12 Jul 2022
Recent News, Updates & Announcement
Biophore subsidiary get CDSCO nod for Cannabidiol active ingredient product.The Hindu 15 May 2023
- Akums enters into a pact with Leiutis Biophore for bringing therapeutics to India.
This association is set to bring succour in therapy areas of CNS disorders pain management and hormonal disorders where there is a gap in meeting the needs of patients in an effective safe and convenient manner .
Economic Times 12 Mar 2023
- Oakrum Pharma and Biophore Announce Product Development and Commercialization Partnership.
PRNewswire Oakrum Pharma LLC Oakrum announced today that it has entered into an agreement with Biophore India Pharmaceuticals Pvt Ltd Biophore to.
PR Newswire 22 Apr 2019
- Amerigen and Biophore Collaborate on Penicillamine Generics.
Amerigen Pharma and Biophore today announced that they are collaborating to bring a generic version of Valeant39s Cuprimine and other penicillamine based generic products to the US market using active pharmaceutical ingredient supplied by Biophore from India .
BioSpace 25 Oct 2017
Frequently asked questions
What is the Incorporation or founding date of Biophore India Pharmaceuticals Private Limited?
